1. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis

   • Andrew Burke
   • Daniel Smith
   • Jason A. Roberts

   Review Article 13 May 2021 Pages: 1081 - 1102

2. Clinical Pharmacokinetics of Triazoles in Pediatric Patients

   • Didi Bury
   • Wim J. E. Tissing
   • Roger J. Brüggemann

   Review Article Open access 18 May 2021 Pages: 1103 - 1147

3. Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review

   • Luka Verrest
   • Erica A. Wilthagen
   • Thomas P. C. Dorlo

   Systematic Review Open access 01 June 2021 Pages: 1149 - 1169

   

4. Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects

   • Andreas B. Jordy
   • Muna Albayaty
   • Tine A. Bækdal

   Original Research Article Open access 30 March 2021 Pages: 1171 - 1185

   

5. Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions

   • Marie-Emilie Willemin
   • Thomas K. Van Der Made
   • Jan Snoeys

   Original Research Article 10 April 2021 Pages: 1187 - 1199

   

6. Model-Based Estimation of Iohexol Plasma Clearance for Pragmatic Renal Function Determination in the Renal Transplantation Setting

   • Tom C. Zwart
   • Aiko P. J. de Vries
   • Dirk Jan A. R. Moes

   Original Research Article Open access 17 April 2021 Pages: 1201 - 1215

   

7. Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin^® in Children and Adults

   • Theodoros Papathanasiou
   • Henrik Agersø
   • Rasmus Juul Kildemoes

   Original Research Article Open access 17 April 2021 Pages: 1217 - 1226

   

8. An Exposure-Response Analysis of the Clinical Efficacy of Ponesimod in a Randomized Phase II Study in Patients with Multiple Sclerosis

   • Per Olsson Gisleskog
   • Belén Valenzuela
   • Italo Poggesi

   Original Research Article 29 April 2021 Pages: 1227 - 1237

   

9. Effect of Ponesimod Exposure on Total Lymphocyte Dynamics in Patients with Multiple Sclerosis

   • Belén Valenzuela
   • Juan-José Pérez-Ruixo
   • Italo Poggesi

   Original Research Article 29 April 2021 Pages: 1239 - 1250

   

10. Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor

    • Angela Joubert James
    • Catherine C. Smith
    • Erkut Bahceci

    Correction Open access 23 July 2021 Pages: 1251 - 1251